tv3326 has been researched along with sesone in 1 studies
| Studies (tv3326) | Trials (tv3326) | Recent Studies (post-2010) (tv3326) | Studies (sesone) | Trials (sesone) | Recent Studies (post-2010) (sesone) |
|---|---|---|---|---|---|
| 15 | 0 | 11 | 29 | 0 | 18 |
| Protein | Taxonomy | tv3326 (IC50) | sesone (IC50) |
|---|---|---|---|
| Thymidine phosphorylase | Escherichia coli K-12 | 6.5 | |
| Thymidine phosphorylase | Homo sapiens (human) | 6.3 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.7 | |
| Beta-secretase 1 | Homo sapiens (human) | 0.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, S; Guan, J; Lin, JP; Liu, XH; Wang, T; Wu, MB; Yang, LR | 1 |
1 review(s) available for tv3326 and sesone
| Article | Year |
|---|---|
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Drug Discovery; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents | 2019 |